Evidence map›Paper›PMID 28895944›Full record

ArticleScientific data2017

Genome wide in vivo mouse screen data from studies to assess host regulation of metastatic colonisation.

Louise van der Weyden, Natasha A Karp, Agnieszka Swiatkowska, David J Adams, Anneliese O Speak

Open access · goldAbstract readDataset
In one paragraph

Article in Scientific data, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
0.6field-weighted citation impact, top 35% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 9 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 1 country.

Louise van der WeydenWellcome Trust Sanger Institute, Wellcome Genome Campus, Hinxton CB10 1SA, UK.
Natasha A KarpWellcome Trust Sanger Institute, Wellcome Genome Campus, Hinxton CB10 1SA, UK.
Agnieszka SwiatkowskaWellcome Trust Sanger Institute, Wellcome Genome Campus, Hinxton CB10 1SA, UK.
David J AdamsWellcome Trust Sanger Institute, Wellcome Genome Campus, Hinxton CB10 1SA, UK.
Anneliese O SpeakWellcome Trust Sanger Institute, Wellcome Genome Campus, Hinxton CB10 1SA, UK.ORCID 0000-0003-4890-4685
Wellcome Sanger Institute · GBAstraZeneca (United Kingdom) · GB

Funding

STANFORD COMPOSITE(RMI)U54HG004028 · NHGRI · STANFORD UNIVERSITY · PI MUSEN, MARK A · 2005 to 2014
$36.2M
Cancer Research UK 13031NHGRI NIH HHS U54 HG004028Wellcome Trust
6 · The paper itself

Abstract

The process of metastasis is a multi-stage cascade with prior studies suggesting that the colonisation of the secondary site is the rate limiting step. This process involves contributions from the tumour cells and also non-tumour intrinsic factors such as the stroma and the haematopoietic system. In this study, we present data from screening 810 genetically-modified mouse lines with the experimental metastasis assay where intravenous delivery of murine metastatic melanoma B16-F10 cells was used to assess the formation of pulmonary metastasic foci. To date, these data have been studied with a two-step process cumulating in an integrative data analysis to identify genes controlling metastatic colonisation. We present the raw data, and a description to support fresh analyses where researchers can look both within and across gene sets to further elucidate process that regulate metastatic colonisation.

Indexed as

Melanoma, ExperimentalAnimalsGenome-Wide Association StudyMiceMice, Inbred C57BLNeoplasm Metastasis

Identifiers

PMID28895944
PMCPMC5827107
OpenAlexW2752289052

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.